Header Logo

Connection

Mohammed Rassool to Coinfection

This is a "connection" page, showing publications Mohammed Rassool has written about Coinfection.
Connection Strength

0,173
  1. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS. 2017 10 23; 31(16):2217-2225.
    View in: PubMed
    Score: 0,122
  2. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial. Lancet HIV. 2017 11; 4(11):e486-e494.
    View in: PubMed
    Score: 0,030
  3. Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa. J Neurovirol. 2012 Jun; 18(3):162-71.
    View in: PubMed
    Score: 0,021
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.